What is the appropriate dose of Fixcom (unknown components) for a 67-year-old patient with chronic hepatitis B infection, weighing 52kg, and undergoing ongoing treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fixcom Dosing Information Not Available in Evidence

I cannot provide a specific dose recommendation for "Fixcom" because this medication is not mentioned in any of the provided evidence, and it does not appear to be a recognized treatment for chronic hepatitis B in standard guidelines.

Critical Issue with the Question

The term "Fixcom" does not appear in:

  • EASL (European Association for the Study of the Liver) guidelines 1
  • AASLD (American Association for the Study of Liver Diseases) recommendations 1
  • Any hepatitis B treatment literature provided 2, 3, 4, 5, 6

Standard Treatment Options for Chronic Hepatitis B

For a 67-year-old patient weighing 52kg with chronic hepatitis B on ongoing treatment, the established first-line therapies are:

Nucleos(t)ide Analogues (Preferred)

  • Entecavir: 0.5 mg once daily (for nucleoside-naïve patients with normal renal function) 1, 7
  • Tenofovir disoproxil fumarate (TDF): 245 mg once daily 1, 7
  • Tenofovir alafenamide (TAF): preferred for patients with renal or bone concerns 7

Dose Adjustments for This Patient

  • Weight consideration: At 52kg, standard adult dosing applies for entecavir and tenofovir - no weight-based adjustment needed 1
  • Age consideration: At 67 years, renal function monitoring is essential, particularly if on tenofovir 7, 8
  • Renal function: Entecavir requires dose adjustment if creatinine clearance <50 mL/min 8

Alternative Agents (Not First-Line)

  • Lamivudine: 100 mg daily (higher resistance rates, not preferred) 1
  • Adefovir: 10 mg daily (nephrotoxicity concerns, especially in elderly) 1
  • Peginterferon alfa-2a: 180 μg weekly (subcutaneous injection, finite duration option) 1

Recommendation for Clinical Action

You must clarify what "Fixcom" refers to - possibilities include:

  • A combination product not available in your region
  • A brand name for a standard hepatitis B medication
  • A medication prescribed for a different indication

If the patient is already on ongoing treatment, verify the actual medication name and ensure it is one of the guideline-recommended agents with high genetic barrier to resistance (entecavir, tenofovir) 7, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of chronic hepatitis B.

Minerva gastroenterologica e dietologica, 2004

Research

Treatment of chronic hepatitis B: who to treat, what to use, and for how long?

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004

Guideline

Hepatitis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antiviral Therapy for HBV-Positive Patients with Sepsis and Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.